Gamco Investors INC. ET AL increased its position in Endo International plc - by 1.7% in the fourth quarter. The share price was last seen 1.18% higher, reaching at $8.6 on October 10, 2017. Coughlin now owns $1,082,481 of the stock per the Form 4 SEC filing. A total of 2.16 Million shares exchanged hands, whereas the company's average trading volume stands at 5.9 Million shares. TIAA CREF Investment Management LLC lifted its position in shares of Endo International PLC by 1.6% during the 2nd quarter. There has been an observed change of 3.27% in the ownership of the shares in the past six months.
Additionally on 8/10/17 Morgan Stanley "Maintained" Endo Int'l Plc (NASDAQ:ENDP) to Equal-Weight setting price target at $8 and on 8/09/17 Deutsche Bank "Maintained" the stock to Buy at $13. Following the purchase, the chief financial officer now owns 13,729 shares of the company's stock, valued at $108,321.81. American International Group Inc. grew its holdings in Endo International PLC by 451.5% in the first quarter.
Shares of Endo Int'l Plc (NASDAQ:ENDP) plunged -0.93% or -0.08 to reach at $8.5 during previous trading session. The firm's market capitalization is $1.92 billion.
Pornhub Users Targeted With Malware Laden Ads
A man looks at pornography online, Hanover, Germany, 25 January 2006. This article has been updated to include a comment from PornHub .
Endo Int'l Plc (NASDAQ:ENDP) 52-week high price stands at $21.87 and low price stands at $7.41, its price distance from 52-week high is -60.68% while its distance from 52-week low price is 16.02%. The company reported $1.23 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.10 by $0.13. Endo International PLC had a negative net margin of 126.93% and a positive return on equity of 37.58%. The business had revenue of $875.73 million for the quarter, compared to analysts' expectations of $832.66 million. Endo International plc -'s revenue for the quarter was up 7.7% on a year-over-year basis. Analysts predict that Endo International PLC will post $3.52 EPS for the current year.
ENDP has been the topic of a number of research analyst reports.
Endo International plc (ENDP) reported sales (ttm) of 4.04 Billion, whereas, 16 number of analysts estimated the mean sale of 775.08 million. Canaccord Genuity initiated the shares of ENDP in report on Wednesday, February 22 with "Hold" rating. Short-term traders are anticipated to see a retreat of -26.52% over the course of a quarter and, with 90% chance the price will be floating in the range of $3.91 and $6.91 in this timeframe. A break down through the support point at $9.41 will initially suggest a lower tendency for declines in the price and this might very well be an early sign that a trend shift is coming.
Demi Lovato Explores Her Struggles in 'Simply Complicated' Documentary Trailer
In a trip down memory lane, Demi Lovato reminisced about Joe Jonas and pinpointed the exact moment she fell in love with him. She's opened up about getting sober, staying sober, and how her life has changed since seeking help.
In other Endo International PLC news, CFO Blaise Coleman purchased 6,500 shares of the stock in a transaction on Tuesday, August 15th. Endo International PLC now has an average rating of "Hold" and an average price target of $12.80.
Analysts are speculating a 68.35% move, based on the high target price ($5) for the shares that is set to reach in the next 12 months. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Its International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, and oncology; generic, branded generic, and over-the-counter products in the areas of dermatology and anti-infectives; and healthcare services, products, and solutions to hospitals, pharmacies, and practitioners, as well as for government healthcare programs. The company's U.S. Branded Pharmaceuticals segment offers pain management products, such as Lidoderm, OPAN ER, Percocet, and Voltare Gel.
Knicks sign free agent point guard Trey Burke
With the regular season just one week away, the front office is looking to shake up its roster by adding one more name to the mix. It was rumored that Burke would be joining the Oklahoma City Thunder, but reportedly backed out in favor of the Knicks .